IFCI
IFCI
Financial ServicesKey Fundamentals
SmallcapFinancial InstitutionFinancial ServicesTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -0.05% over past five years.
- Company has a low return on equity of 2.29% over last 3 years.
Growth Rate
AI Analysis — Bull vs Bear
IFCI Ltd is a government-backed financial institution with a market cap of ₹22,524 Cr trading at a P/E of 52.9x and P/B of 2.56x. The company has shown a sharp stock price rally (75% CAGR over 3 years) but underlying fundamentals remain weak with near-flat sales growth over 5 years, a TTM profit decline of -44%, and a 3-year average ROE of just 2%.
- Strong stock price momentum with 1-year CAGR of 58% and 3-year CAGR of 75%, reflecting sustained market interest
- Company has turned profitable on a 3-year compounded basis with profit growth of 41% CAGR over 3 years, reversing years of losses
- 5-year compounded profit growth of 16% indicates a structural shift from loss-making to sustained profitability
- Government-owned development financial institution status provides implicit sovereign backing, reducing existential risk
- 10-year stock CAGR of 12% shows long-term wealth creation despite periods of severe fundamental weakness
- ROE has improved to 2% in the last year versus a negative -8% over 10 years, suggesting a turnaround trajectory
- TTM sales growth of 5% marks an improvement over the 5-year compounded sales growth of approximately 0%, hinting at a possible revenue recovery
- P/E ratio of 52.9x is significantly elevated for a financial services company with weak underlying growth, suggesting expensive valuation
- 5-year compounded sales growth is virtually flat at -0.05%, indicating no meaningful top-line expansion over a long period
- TTM profit has declined -44%, showing that the recent profitability trend may already be reversing
- 3-year average ROE of just 2.29% is extremely low for a financial services firm, indicating poor capital efficiency
- 10-year compounded sales growth of -7% reflects a structurally shrinking revenue base over the long term
- Zero dividend yield despite reporting repeated profits suggests either weak cash generation or the need to retain capital for balance sheet repair
- Trading at 2.56x book value is expensive for a company generating only 2% ROE — a sustainable P/B premium typically requires ROE well above cost of equity
- 10-year compounded profit growth of -6% indicates the recent profitability is an exception to a long-term trend of value erosion
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- P/E at 57x, overbought RSI 71.7 Sep 9
IFCI's price-to-earnings ratio has ballooned to ~57x, far above sector averages. RSI at 71.7 indicates overbought conditions, and single-day volumes hit 428M shares — 18x normal average, suggesting heavy speculative momentum.
- 10% crash on profit booking Sep 8
IFCI shares plummeted 10.12% to ₹92.13 on Sep 8 with 217M shares traded, despite no negative news. Classic 'buy the rumor, sell the news' distribution after a 25% rally in two weeks.
- Valuation hinges on NSE event Sep 9
Nearly half of IFCI's ~₹25,000-28,700 crore market cap is derived from its indirect 2.2-2.35% NSE exposure via SHCIL. If the NSE IPO disappoints or faces delays, IFCI could face sharp de-rating.
- Core business modest vs hype Sep 9
FY27 Q1 net profit was ₹92.6 crore, but standalone valuation contribution is modest compared to the NSE-driven narrative. Current valuation is heavily dependent on event-driven catalysts rather than operational performance.
- SEBI approves ₹30,000 cr NSE IPO Sep 2
SEBI issued its observation letter on Sep 4, clearing NSE's ₹30,000 crore IPO (OFS of 14.89 crore shares at ~₹1,800/share). IPO launch expected Sep 15 with listing targeted Sep 24-25, removing a decade-long regulatory overhang.
- IFCI surges on NSE exposure Sep 2
IFCI shares hit all-time high of ₹107.36, up 6% on Sep 2 and over 100% YTD in 2026. IFCI's 52.86% stake in SHCIL (which holds 4.4% of NSE) implies ~₹11,730 crore embedded value at ₹5 lakh crore NSE valuation.
- NSE GMP soars post approval Sep 2
NSE grey market premium jumped to ₹250-280/share from ₹150-180 after SEBI's Friday approval, with unlisted market trades near ₹1,970-2,000. NSE targets valuation of up to ₹5.26 lakh crore ($55B).
- Technical breakout above ₹95 Sep 8
Analysts note IFCI broke above its previous swing high of ₹95.80, with support at ₹95.5-96 and upside targets at ₹110, ₹120, and ₹126.33 (61.8% Fibonacci extension). Stock trades above all 8 key SMAs.
- NSE's dominant market moat Sep 9
NSE commands ~93% of India's equity cash-market turnover and 99.8% of equity futures turnover, and has been the world's largest derivatives exchange by volume for 5 consecutive years.
- IFCI files FY26 BRSR report Sep 2
IFCI Limited filed its Business Responsibility and Sustainability Report for FY26, detailing employee welfare, energy usage, and regulatory compliance metrics.
- 33rd AGM scheduled Sep 25 Sep 2
IFCI announced its 33rd Annual General Meeting for September 25, 2026, to be held via video conference with electronic access to the annual report.
- NSE IPO launch on Anant Chaturdashi Sep 2
NSE is reportedly expecting its IPO launch on Anant Chaturdashi, with listing targeted before Pitru Paksha begins on September 26.
TL;DR: IFCI is riding an explosive rally driven almost entirely by its indirect NSE exposure via SHCIL, with shares up 100%+ YTD after SEBI's Sep 4 approval of NSE's ₹30,000 crore IPO. The embedded NSE value (~₹11,730 crore) is real, but at a P/E of 57x and after a 10% profit-booking crash on Sep 8, much of the upside may already be priced in. Core business fundamentals (Q1 profit ₹92.6 crore) are modest relative to the market cap of ~₹25,000-28,700 crore. The near-term trajectory depends heavily on NSE's IPO pricing and listing success around Sep 24-25 — any disappointment could trigger a sharp de-rating.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 320 | 607 | 454 | 605 | 388 | 617 | 459 | 414 | 407 | 735 | 456 | 470 | 327 |
| Expenses | 290 | -74 | 230 | 269 | 210 | 353 | 211 | -80 | 215 | 243 | 326 | 314 | 138 |
| Financing Profit | -114 | 535 | 78 | 201 | 43 | 130 | 117 | 359 | 88 | 385 | 27 | 54 | 85 |
| Fin. Margin % | -36% | 88% | 17% | 33% | 11% | 21% | 25% | 87% | 22% | 52% | 6% | 11% | 26% |
| Other Income | 4 | 5 | 14 | 107 | 17 | 167 | -2 | 1 | 36 | 17 | 6 | -4 | 31 |
| Interest | 144 | 145 | 146 | 136 | 135 | 135 | 131 | 134 | 104 | 107 | 103 | 102 | 104 |
| Depreciation | 18 | 21 | 21 | 21 | 20 | 22 | 21 | 21 | 21 | 21 | 21 | 23 | 20 |
| PBT | -128 | 520 | 71 | 287 | 40 | 275 | 94 | 340 | 103 | 381 | 13 | 27 | 96 |
| Tax % | 1% | 66% | 45% | 45% | 318% | 33% | 109% | 23% | 39% | 17% | -66% | -24% | 37% |
| Net Profit | -129 | 174 | 39 | 157 | -88 | 185 | -9 | 260 | 62 | 317 | 21 | 34 | 60 |
| EPS in Rs | -0.64 | 0.44 | 0.08 | 0.61 | -0.41 | 0.32 | -0.12 | 0.84 | 0.15 | 0.53 | -0.06 | 0.05 | 0.12 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,864 | 4,465 | 3,582 | 4,322 | 2,821 | 2,880 | 2,082 | 1,556 | 1,699 | 1,988 | 2,021 | 2,077 | 1,988 |
| Expenses | 1,010 | 1,509 | 1,850 | 1,714 | 1,962 | 1,463 | 2,961 | 2,108 | 986 | 715 | 694 | 1,097 | 1,021 |
| Financing Profit | 681 | 357 | -647 | 463 | -944 | -34 | -2,026 | -1,496 | 72 | 702 | 793 | 564 | 551 |
| Fin. Margin % | 18% | 8% | -18% | 11% | -33% | -1% | -97% | -96% | 4% | 35% | 39% | 27% | 28% |
| Other Income | 82 | 168 | 99 | 38 | 311 | 21 | 14 | 39 | 28 | 130 | 40 | 46 | 50 |
| Interest | 2,173 | 2,599 | 2,380 | 2,144 | 1,803 | 1,451 | 1,147 | 943 | 642 | 571 | 535 | 416 | 416 |
| Depreciation | -11 | 24 | 61 | 63 | 63 | 81 | 72 | 66 | 74 | 81 | 83 | 86 | 85 |
| PBT | 775 | 501 | -609 | 439 | -696 | -94 | -2,085 | -1,523 | 26 | 751 | 749 | 524 | 517 |
| Tax % | 28% | 24% | -47% | 5% | -32% | 137% | -8% | 16% | 559% | 68% | 53% | 17% | — |
| Net Profit | 575 | 394 | -308 | 418 | -476 | -223 | -1,912 | -1,761 | -120 | 241 | 349 | 435 | 433 |
| EPS in Rs | 3.23 | 2.18 | -2.27 | 2.26 | -2.88 | -1.36 | -10.24 | -8.71 | -0.95 | 0.47 | 0.63 | 0.67 | 0.64 |
| Div. Payout % | 46% | 46% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1,662 | 1,662 | 1,662 | 1,696 | 1,696 | 1,696 | 1,896 | 2,103 | 2,196 | 2,490 | 2,694 | 2,694 |
| Reserves | 5,561 | 5,639 | 5,208 | 4,193 | 3,661 | 3,553 | 1,842 | 715 | 1,571 | 2,045 | 5,996 | 6,250 |
| Borrowing | 26,767 | 28,598 | 23,919 | 20,665 | 16,394 | 12,566 | 11,041 | 7,095 | 6,020 | 5,367 | 3,714 | 3,523 |
| Other Liabilities | 2,980 | 3,247 | 3,493 | 4,244 | 4,291 | 4,623 | 5,585 | 5,574 | 7,152 | 9,016 | 13,319 | 14,103 |
| Total Liabilities | 36,970 | 39,146 | 34,282 | 30,798 | 26,042 | 22,439 | 20,364 | 15,487 | 16,939 | 18,918 | 25,724 | 26,570 |
| Fixed Assets | 1,935 | 1,860 | 1,823 | 1,721 | 1,701 | 1,720 | 1,762 | 1,741 | 1,764 | 1,734 | 1,700 | 1,486 |
| CWIP | 4 | 6 | 3 | 2 | 1 | 4 | 9 | 16 | 11 | 13 | 23 | 0 |
| Investments | 6,330 | 6,860 | 5,150 | 7,363 | 5,580 | 3,963 | 5,504 | 6,541 | 7,700 | 8,678 | 15,323 | 15,081 |
| Other Assets | 28,700 | 30,420 | 27,306 | 21,712 | 18,760 | 16,752 | 13,089 | 7,190 | 7,464 | 8,493 | 8,678 | 10,004 |
| Total Assets | 36,970 | 39,146 | 34,282 | 30,798 | 26,042 | 22,439 | 20,364 | 15,487 | 16,939 | 18,918 | 25,724 | 26,570 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 263 | -5 | 802 | -972 | 444 | 635 | -438 | -257 | -336 | 12 | -984 | 280 |
| Investing | 7 | 77 | -8 | 195 | -23 | -33 | -103 | -30 | -59 | -155 | -70 | 25 |
| Financing | -409 | -316 | -29 | 43 | -234 | 196 | 193 | 73 | 465 | 404 | 415 | -149 |
| Net Cash Flow | -138 | -245 | 765 | -734 | 186 | 798 | -348 | -213 | 70 | 261 | -638 | 156 |
| Free Cash Flow | 270 | 71 | 794 | -1,003 | 405 | 603 | -545 | -288 | -383 | -24 | -1,011 | 313 |
| CFO/OP | 14 | 5 | 49 | -35 | 63 | 48 | 50 | 46 | -39 | 6 | -71 | 36 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | 7% | 4% | -6% | 6% | -12% | -4% | -43% | -56% | -6% | 2% | 3% | 2% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view IFCI insights
54 extracted metrics + investor summaries across FY04–FY26.
Documents
Frequently Asked Questions about IFCI
What does IFCI Ltd do?
Where is IFCI Ltd (IFCI) listed?
Which sector does IFCI Ltd belong to?
What is the market capitalisation of IFCI Ltd?
What is the PE ratio of IFCI Ltd?
What is the 52-week high and low of IFCI Ltd?
What is the Return on Equity (ROE) of IFCI Ltd?
Company Information
IFCI, previously known as Industrial Finance Corporation of India, is an Indian Government owned non banking finance company established to cater to the long-term finance needs of the industrial sector. [1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/IFCI.md for IFCI Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.